List of Excipients in API VALSARTAN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing VALSARTAN
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | FERRIC OXIDE YELLOW | |
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | HYPROMELLOSES | |
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | MAGNESIUM STEARATE | |
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | POLYETHYLENE GLYCOL 8000 | |
| Novartis Pharmaceuticals Corporation | DIOVAN | valsartan | 0078-0423 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing VALSARTAN
Detailed excipient profiles for VALSARTAN
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
VALSARTAN drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | valsartan and hydrochlorothiazide | 68382-279 |
| Zydus Lifesciences Limited | valsartan and hydrochlorothiazide | 70771-1485 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
VALSARTAN drug variants containing ANHYDROUS LACTOSE
VALSARTAN drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BLUE 1
VALSARTAN drug variants containing BLUE 1
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7442 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing BLUE 1
Excipient focus: CELLULOSE, MICROCRYSTALLINE
VALSARTAN drug variants containing CELLULOSE, MICROCRYSTALLINE
VALSARTAN drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Northwind Pharmaceuticals LLC | valsartan | 51655-244 |
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 77891
VALSARTAN drug variants containing CI 77891
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7442 |
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7443 |
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7444 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing CI 77891
Excipient focus: CROSCARMELLOSE SODIUM
VALSARTAN drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valsartan | 31722-151 |
| Camber Pharmaceuticals Inc | valsartan | 31722-745 |
| AvKARE | valsartan | 42291-856 |
| AvKARE | valsartan | 42291-857 |
| Medsource Pharmaceuticals | valsartan | 45865-114 |
| Alembic Pharmaceuticals Limited | valsartan | 46708-044 |
| A-S Medication Solutions | valsartan | 50090-2255 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
VALSARTAN drug variants containing CROSPOVIDONE
VALSARTAN drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | valsartan | 31722-151 |
| Camber Pharmaceuticals Inc | valsartan | 31722-745 |
| AvKARE | valsartan | 42291-856 |
| AvKARE | valsartan | 42291-857 |
| Medsource Pharmaceuticals | valsartan | 45865-114 |
| Alembic Pharmaceuticals Limited | valsartan | 46708-044 |
| A-S Medication Solutions | valsartan | 50090-2255 |
| >Company | >Ingredient | >NDC |
Excipient focus: CURRY RED
VALSARTAN drug variants containing CURRY RED
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7442 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing CURRY RED
Excipient focus: FD&C BLUE NO. 1
VALSARTAN drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-6232 |
| Preferred Pharmaceuticals Inc | valsartan and hydrochlorothiazide | 68788-8463 |
| Bryant Ranch Prepack | valsartan and hydrochlorothiazide | 71335-2617 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
VALSARTAN drug variants containing FD&C BLUE NO. 2
VALSARTAN drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
VALSARTAN drug variants containing FD&C RED NO. 40
VALSARTAN drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
VALSARTAN drug variants containing FD&C YELLOW NO. 6
VALSARTAN drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
VALSARTAN drug variants containing FERRIC OXIDE RED
VALSARTAN drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
VALSARTAN drug variants containing FERRIC OXIDE YELLOW
VALSARTAN drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
VALSARTAN drug variants containing FERROSOFERRIC OXIDE
VALSARTAN drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HEMATITE
VALSARTAN drug variants containing HEMATITE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7443 |
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7444 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing HEMATITE
Excipient focus: HYDROXYPROPYL CELLULOSE
VALSARTAN drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-2640 |
| DirectRX | valsartan and hydrochlorothiazide | 61919-634 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 63187-428 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 71205-004 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
VALSARTAN drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| DirectRX | valsartan and hydrochlorothiazide | 61919-634 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
VALSARTAN drug variants containing HYPROMELLOSE
VALSARTAN drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
VALSARTAN drug variants containing HYPROMELLOSE 2910
VALSARTAN drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
VALSARTAN drug variants containing HYPROMELLOSES
VALSARTAN drug variants not containing HYPROMELLOSES
Excipient focus: INDIGOTINDISULFONATE SODIUM
VALSARTAN drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Unit Dose Services | valsartan | 50436-2168 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: LACTOSE MONOHYDRATE
VALSARTAN drug variants containing LACTOSE MONOHYDRATE
VALSARTAN drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
VALSARTAN drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-2640 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 63187-428 |
| Proficient Rx LP | valsartan and hydrochlorothiazide | 71205-004 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
VALSARTAN drug variants containing MAGNESIUM STEARATE
VALSARTAN drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
VALSARTAN drug variants containing MANNITOL
VALSARTAN drug variants not containing MANNITOL
Excipient focus: METHYLPARABEN
VALSARTAN drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing METHYLPARABEN
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
VALSARTAN drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Northwind Pharmaceuticals LLC | valsartan | 51655-244 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
VALSARTAN drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Northwind Pharmaceuticals LLC | valsartan | 51655-244 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: PEG-75
VALSARTAN drug variants containing PEG-75
VALSARTAN drug variants not containing PEG-75
Excipient focus: POLOXAMER 188
VALSARTAN drug variants containing POLOXAMER 188
VALSARTAN drug variants not containing POLOXAMER 188
Excipient focus: POLYDEXTROSE
VALSARTAN drug variants containing POLYDEXTROSE
VALSARTAN drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
VALSARTAN drug variants containing POLYETHYLENE GLYCOL
VALSARTAN drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
VALSARTAN drug variants containing POLYETHYLENE GLYCOL 3350
VALSARTAN drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
VALSARTAN drug variants containing POLYETHYLENE GLYCOL 400
VALSARTAN drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
VALSARTAN drug variants containing POLYETHYLENE GLYCOL 4000
VALSARTAN drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 6000
VALSARTAN drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | valsartan | 70771-1882 |
| Viona Pharmaceuticals Inc | valsartan | 72578-131 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
VALSARTAN drug variants containing POLYETHYLENE GLYCOL 8000
VALSARTAN drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
VALSARTAN drug variants containing POLYETHYLENE GLYCOLS
VALSARTAN drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYVINYL ALCOHOL
VALSARTAN drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | valsartan | 42291-856 |
| AvKARE | valsartan | 42291-857 |
| Solco Healthcare US LLC | valsartan | 43547-367 |
| A-S Medication Solutions | valsartan | 50090-2424 |
| A-S Medication Solutions | valsartan | 50090-7312 |
| Unit Dose Services | valsartan | 50436-2168 |
| Northwind Pharmaceuticals LLC | valsartan | 51655-653 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POTASSIUM SORBATE
VALSARTAN drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing POTASSIUM SORBATE
Excipient focus: POVIDONE
VALSARTAN drug variants containing POVIDONE
VALSARTAN drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
VALSARTAN drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | valsartan | 0378-5807 |
| Unichem Pharmaceuticals (USA) Inc | valsartan | 29300-232 |
| Unit Dose Services | valsartan | 50436-2168 |
| Northwind Pharmaceuticals LLC | valsartan | 51655-244 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
VALSARTAN drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing PROPYLENE GLYCOL
Excipient focus: SAND
VALSARTAN drug variants containing SAND
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7442 |
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7443 |
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7444 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing SAND
Excipient focus: SILICA
VALSARTAN drug variants containing SILICA
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan | 50090-2424 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing SILICA
Excipient focus: SILICON DIOXIDE
VALSARTAN drug variants containing SILICON DIOXIDE
VALSARTAN drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
VALSARTAN drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
VALSARTAN drug variants containing SODIUM LAURYL SULFATE
VALSARTAN drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
VALSARTAN drug variants containing STARCH, CORN
VALSARTAN drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
VALSARTAN drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | valsartan and hydrochlorothiazide | 57297-103 |
| Dispensing Solutions Inc | valsartan and hydrochlorothiazide | 68258-6969 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: SUCRALOSE
VALSARTAN drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing SUCRALOSE
Excipient focus: TALC
VALSARTAN drug variants containing TALC
VALSARTAN drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
VALSARTAN drug variants containing TITANIUM DIOXIDE
VALSARTAN drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
VALSARTAN drug variants containing TRIACETIN
VALSARTAN drug variants not containing TRIACETIN
Excipient focus: TRISODIUM CITRATE DIHYDRATE
VALSARTAN drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: VANILLIN
VALSARTAN drug variants containing VANILLIN
VALSARTAN drug variants not containing VANILLIN
Excipient focus: WATER
VALSARTAN drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | valsartan | 70954-310 |
| Lifsa Drugs LLC | valsartan | 72336-910 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing WATER
Excipient focus: YELLOW 6
VALSARTAN drug variants containing YELLOW 6
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | valsartan and hydrochlorothiazide | 50090-7442 |
| >Company | >Ingredient | >NDC |
VALSARTAN drug variants not containing YELLOW 6
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links